AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Mounika Nagarani Tunuguntla, Guntur Medical college- Guntur, India
Citation: Mounika N. Tunuguntla, Pranathi Chanti, Reddy Ummadi VN, Sujith K. Kota, Prashant Obe RD, et al, (2024), Understanding Gut Health: Probiotics, Dysbiosis, and their Connection to Type 2 Diabetes - A Review, International Journal of Clinical Case Reports and Reviews, 18(1); DOI:10.31579/2690-4861/405
Copyright: © 2024, Mounika Nagarani Tunuguntla. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 21 February 2024 | Accepted: 20 March 2024 | Published: 20 June 2024
Keywords: probiotics; type 2 diabetes; dysbiosis; insulin resistance
Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by hyperglycaemia resulting from defects in insulin secretion, insulin action, or both. The pathophysiology of T2DM involves a multifaceted interplay of genetic, behavioural, and environmental factors. Beta cells play a central role in regulating blood glucose levels through intricate mechanisms involving insulin secretion triggered by elevated glucose concentrations and other factors. Dysfunction of beta cells in T2DM encompasses various molecular pathways influenced by factors such as hyperglycaemia, hyperlipidaemia, chronic inflammation, and genetic susceptibility, leading to impaired insulin secretion and insulin resistance.
Recent research has highlighted the role of gut dysbiosis in the pathogenesis of T2DM, with alterations in gut microbiome composition impacting glucose metabolism. Dysbiosis-induced intestinal permeability can lead to systemic inflammation, contributing to insulin resistance and diabetes progression. Conversely, a diverse and rich gut microbiome has been associated with protection against obesity, diabetes, and metabolic syndrome.
Probiotics, defined as live bacteria conferring health benefits when administered in adequate amounts, hold promise in mitigating T2DM-related metabolic derangements through various mechanisms, including modulation of gut microbiota, regulation of the gut-brain axis, and reduction of chronic low-grade inflammation. This provides a comprehensive overview of the mechanisms through which probiotics may positively impact glucose metabolism and discusses current evidence on the efficacy of probiotic supplementation in improving glycemic parameters and highlights the need for further research to elucidate strain-specific effects, optimal dosages, and long-term outcomes. Additionally, the translation of research findings into clinical practice and the potential of microbiome-targeted therapies for precision management of T2DM are explored, underscoring the importance of evidence-based guidelines for healthcare practitioners.
Type 2 diabetes mellitus (T2DM) represents a significant global health burden, characterized by insulin resistance, β-cell dysfunction, and hyperglycaemia. The aetiology of T2DM is multifaceted, involving complex interactions between genetic predisposition, lifestyle factors, and environmental influences. Dysbiosis of the gut microbiome, marked by alterations in microbial composition and function, has emerged as a compelling factor contributing to T2DM pathogenesis. In individuals with T2DM, dysbiosis disrupts intestinal barrier integrity, leading to the translocation of bacteria and their metabolites into systemic circulation, thereby triggering a pro-inflammatory state and exacerbating insulin resistance.
Probiotics, comprising live beneficial bacteria, offer a promising avenue for mitigating T2DM-related metabolic disturbances. Through modulation of gut microbiota composition and function, probiotics exert beneficial effects on glucose homeostasis. Studies have demonstrated that probiotic supplementation improves glycaemic parameters, including fasting blood glucose, insulin sensitivity, and HbA1c levels, in individuals with T2DM. Mechanisms underlying these effects involve the production of short-chain fatty acids (SCFAs), modulation of the gut-brain axis, and reduction of chronic low-grade inflammation.
Despite promising findings, challenges remain in translating research outcomes into clinical practice. Strain-specific effects, optimal dosages, and long-term safety considerations warrant further investigation. Moreover, the development of microbiome-targeted therapies holds potential for personalized management strategies tailored to individual microbial profiles. By bridging the gap between experimental evidence and clinical application, probiotics offer a promising therapeutic avenue for precision management of T2DM, emphasizing the need for evidence-based guidelines to guide healthcare practitioners in optimizing patient care.
PRISMA guidelines have been followed for conducting the review.
Search Strategy:
Two researchers have conducted an independent literature search on the PubMed and Google Scholar for the Randomised controlled trials published since the inception of the databases using the keywords “PROBIOTICS “, “TYPE 2 DIABETES”, and “GLYCEMIC CONTROL “and the results were matched to ensure that they were correct.
Study Selection:
All the retrieved articles were initially screened for the Title and Abstract.
Inclusion and Exclusion Criteria:
All Randomized control trials published in English with no restriction on publication date to ensure comprehensive were selected with the following PICO characteristics
Type 2 Diabetes - Background and pathophysiology
Diabetes is defined by the American Diabetes Association as a group of metabolic diseases characterized by hyperglycaemia resulting from defects in either insulin secretion, insulin action, or both [1]. It occurs because of a very complex interplay between Genetic, Behavioural, and environmental factors. Type 1 Diabetes is characterized by absolute or near absolute insulin deficiency whereas type 2 diabetes also has a component of Insulin Resistance where insulin cannot act on the peripheral tissues to exert its effect.
Beta cells orchestrate an intricate and precisely synchronized response to increasing blood glucose levels. Insulin release from β-cells is primarily triggered by high glucose concentrations. When glucose levels rise, β-cells take in glucose via GLUT2 transporters, increasing the intracellular ATP/ADP ratio [2]. This leads to the closure of ATP-dependent potassium channels and rise in intracellular potassium levels leading to membrane depolarization, and opening of voltage-dependent Ca2+ channels [3]. Ca 2+ influx induces fusion of insulin-containing granules with the plasma membrane, facilitating insulin exocytosis as described in figure 1
Figure 1: Insulin release from Beta cells
The insulin thus released acts on the tyrosine kinase Insulin receptors which on Stimulation activate further downstream signalling pathways as described in FIGURE 2 to exert its effects.
Figure 2: Insulin Signalling at peripheral tissues.
Type 2 diabetes may arise from impairments occurring at any of the aforementioned stages. Insulin resistance denotes a condition characterized by diminished responsiveness of typically insulin-sensitive tissues.[4] This phenomenon typically serves as the primary catalyst for the onset and advancement of type 2 diabetes. [5] Insulin resistance is multifaceted, influenced by various underlying risk factors, and can manifest at different junctures within the intricate pathways of insulin signalling. These include Splicing mutations of the insulin gene or the presence of autoantibodies which target the insulin receptor leading to conditions like Type A and type B IR syndrome respectively [6].
A Proinflammatory state induces insulin resistance by phosphorylating insulin receptor and its substrates via communication through receptors such as tumour necrosis factor receptor 1 (TNFR1) thereby worsening the insulin resistance [7].
These factors collectively disrupt insulin signalling pathways, particularly the MAPK/ERK and PI3K/AKT/mTOR pathways, contributing to insulin resistance.
As the insulin resistance worsens Beta cells compensate by increasing the production of insulin creating a state of hyperinsulinemia [8]. which contributes to the development of cardiovascular disease by various mechanisms most notably endothelial dysfunction and subsequent atheroma plaque progression and ventricular hypertrophy and diastolic dysfunction [9].
β-cell dysfunction in type 2 diabetes mellitus (T2DM) is a complex phenomenon influenced by various factors, and several concepts have been proposed to explain its mechanisms. While these concepts are not mutually exclusive and often interact with each other, they provide valuable insights into understanding the pathophysiology of T2DM. Here are three key concepts:
1. Glucotoxicity: Glucotoxicity refers to the harmful effects of chronically elevated blood glucose levels on pancreatic β-cells.[10] Prolonged exposure to high glucose levels induces oxidative stress, endoplasmic reticulum (ER) stress, and mitochondrial dysfunction in β-cells, ultimately impairing their function and survival [11]. contributing to β-cell apoptosis and decreasing β-cell mass, thereby exacerbating insulin deficiency in T2DM.
2. Lipotoxicity: Lipotoxicity refers to the harmful effects of elevated levels of free fatty acids (FFAs) and lipid metabolites on pancreatic β-cells [12]. insulin-resistant states like T2DM creates a state of dysregulated lipolysis resulting in excessive Free fatty acid production (FFAs). These FFAs accumulate in pancreatic β-cells and interfere with insulin synthesis, secretion, and signalling pathways. Lipid metabolites such as diacylglycerol (DAG) and ceramides activate protein kinase C (PKC) and c-Jun N-terminal kinase (JNK) pathways, leading to impaired insulin gene expression, insulin exocytosis, and insulin receptor signalling. Furthermore, lipotoxicity induces ER stress, mitochondrial dysfunction, and inflammation in β-cells, contributing to their dysfunction and apoptosis.[13]
3. Inflammation and immune-mediated dysfunction: Chronic low-grade inflammation and immune-mediated processes play a significant role in the pathogenesis of T2DM and β-cell dysfunction [14].
In a healthy individual, the gut microbiome primarily comprises Firmicutes and Bacteroidetes phyla, which collectively constitute 60–80% and 20–30% of the gut microbiota, respectively [15] (FIGURE 3) Within the Firmicutes phylum, dominant genera include Lactobacillus, Bacillus, Clostridium, Enterococcus, and Ruminicoccus, while Bacteroides and Prevotella are prominent genera within the Bacteroidetes phylum. Both Firmicutes and Bacteroidetes are known producers of butyrate,[16] a crucial short-chain fatty acid (SCFA) that serves as a primary energy source for colonic epithelial cells, essential for maintaining their integrity. Insufficient levels of butyrate have been linked to increased gut permeability due to damage to colonic epithelial cells [17].
Increased intestinal permeability leads to the translocation of bacteria, their metabolites, and endotoxins into the bloodstream, resulting in bacteraemia and endotoxemia [18].
Bacteraemia refers to the presence of bacteria in the bloodstream, while endotoxemia involves the circulation of endotoxins, primarily lipopolysaccharides (LPS) from gram-negative bacteria. This systemic dissemination triggers an inflammatory response, characterized by the activation of immune cells and the release of pro-inflammatory cytokines like TNF alpha and interleukins with resultant chronic systemic low-grade inflammation [19].
Systemic inflammation induced by bacteraemia and endotoxemia can contribute to the development of insulin resistance, a key component of diabetes pathogenesis as described before as Chronic inflammation disrupts insulin signalling pathways, impairing glucose uptake by target tissues such as muscle and adipose tissue. Additionally, inflammatory cytokines interfere with pancreatic beta-cell function, further exacerbating insulin resistance. Consequently, sustained systemic inflammation can promote the onset and progression of diabetes by disrupting glucose homeostasis and exacerbating insulin resistance.
Butyrate has been shown in in vitro studies in animal models to improve insulin sensitivity [20], by histone deacetylase (HDAC)-mediated transcription regulation and subsequent activation of mitochondrial fatty-acid oxidation [21].
Figure 3: Predominant Gut Microbiota
Actinobacteria, Proteobacteria, Fusobacteria, and Verrucomicrobia are the other phyla that make up the rest 10% of the gut microbiota [9]. Actinobacter phyla are mainly represented by the Bifidobacterium genus.
One study by Jinlan et al found that supplementing with B.animalis 01 1 significantly increased the expression of IRS/PI3K/Akt expression leading to improved insulin sensitivity.[22] Few other probiotics like Bifidobacterium lactis HY8101 or Lactobacillus paracasei TD062, have also been shown to enhance this insulin signalling pathway [23,24].
A Rich microbiome in the gut with various species has been shown to be protective against the development of various chronic diseases like obesity, Diabetes, and metabolic syndrome [25].
People with diabetes have been shown to have a different composition of gut microbiome. A systematic review conducted by Umirah et al has shown that Butyrate-producing bacteria are significantly lower in patients with type 2 diabetes and that treatment with metformin actually altered the situation.(7)[26] Butyrate producing bacteria specifically decreased in T2DM include Clostridiales order, including the genera Ruminococcus and Subdoligranulum, and the species Eubacterium rectale, Faecali prausnitzii, Roseburia intestinalis and Roseburia inulinivorans [27], as summarised in Table 1
| DECREASED IN T2DM | INCREASED IN T2DM |
| Bacteroides | Clostridium hathewayi |
| Prevotella | Clostridium symbiosum |
| Bifidobacterium | Eggerthella |
| Akkermanisa muciniphila | Lenta Clostridium ramosum |
| Faecali prausnitzii | Escherichia coli |
Roseburia intestinalis Roseburia inulinivorus |
Table 1: Gut microbiome in Type 2 Diabetes
Altered Gut Microbiome in Diabetes
The genera Bacteroides, Prevotella and Bifidobacterium are found in significantly less numbers in T2DM patients. This microbiota, improve the intestinal integrity and reduce the translocation of endotoxins and thereby systemic inflammation.
Other microbiota that are significantly reduced in T2DM are of the species Akkermansia muciniphila and Faecali prausnitzii [27].
There is also significant evidence that, there are increased opportunistic pathogens such as Bacteroides caccae, Clostridium hathewayi, Clostridium symbiosum, Eggerthella, lenta Clostridium ramosum, and Escherichia coli [28].
The enumerated examples presented herein represent only a subset of the microbiota implicated in the gut dysbiosis associated with Type 2 Diabetes Mellitus (T2DM). Nevertheless, it is imperative to underscore the need for additional research and comprehensive clinical studies to elucidate the intricate relationship between the gut microbiome and T2DM. Further investigations will contribute invaluable insights into the nuanced dynamics and potential therapeutic implications of these interactions.
Probiotics and type 2 diabetes
Probiotics are defined by FA0/WHO as living bacteria which, when administered in adequate amounts, confer a health benefit on the host [29], and are currently being widely studied for their ability to alter glucose homeostasis. Numerous trials have been done showing the role of probiotic supplementation in improving the glycaemic parameters in diabetes. A systematic review of over 30 RCTs by —- has shown that probiotic supplementation was associated with a significant decline in glycaemic parameters including FBG (SMD = - 0.331, 95% CI - 0.424 to - 0.238, P-effect < 0 xss=removed xss=removed xss=removed xss=removed>
Various mechanisms have been proposed to understand how probiotics improve glucose metabolism and help achieve good glycaemic control. This understanding of the mechanisms is very helpful in directing future studies and making way for novel therapeutic methods to treat Type 2 Diabetes Mellitus.
One of the mechanisms that has been described is via the Modulation of Gut Microbiota. As discussed earlier, Studies reveal a correlation between dysbiosis, characterized by altered gut microbiome composition, and impaired glucose metabolism in individuals with T2DM. Probiotics have demonstrated the ability to restore this dysbiosis by increasing the abundance of beneficial bacteria, such as Lactobacillus and Bifidobacterium. These alterations in gut microbiota contribute to improved glucose homeostasis by enhancing dietary fiber fermentation and subsequent short-chain fatty acids (SCFAs) production, notably butyrate, a prominent SCFA, as described before whs been shown to enhance glucose uptake in peripheral tissues by improving insulin sensitivity [20]. SCFAs also stimulate G protein-coupled receptors (GPCR) on L cells which are neuroendocrine cells present in the ileum that lead to the release of and stimulates the production of Glucagon-like Peptide-1 (GLP-1) which is an incretin meaning that it will stimulate Insulin secretion from the pancreas and promote gastric emptying thus helping with satiety [31].
Another mechanism that has been postulated is via the Modulation of the Gut-Brain Axis. Probiotics exert their influence on the gut-brain axis, a bidirectional communication system linking the gastrointestinal tract to the central nervous system. This axis plays a pivotal role in regulating glucose metabolism and insulin secretion. Probiotics have been found to regulate the release of gut hormones, including glucagon-like peptide-1 (GLP-1) and peptide YY, both crucial in glucose homeostasis. The stimulation of GLP-1 enhances insulin secretion, improves insulin sensitivity, and reduces glucagon secretion, while peptide YY regulates food intake and promotes satiety. Probiotic use may enhance the secretion of these hormones, contributing to improved glycemic control. Reduction of Chronic Low-Grade Inflammation is another potential mechanism linking the use of probiotics in type 2 diabetes. Chronic low-grade inflammation, closely linked to impaired glucose homeostasis and insulin resistance, is mitigated by probiotics through the suppression of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Concurrently, there is an increase in the secretion of anti-inflammatory cytokines, such as interleukin-10 (IL-10). This anti-inflammatory action of probiotics holds promise for attenuating the development of T2DM by improving glucose metabolism and insulin sensitivity.
| Type of Probiotic | Altered Glycaemic parameters | Duration of intervention | Reference |
Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 | FFG - Mean difference of 12.6mg/dl (p= 0.009)
HbA1C- Mean difference of 0.12%(p=0.019) | 6 weeks | [32] |
| Bifidobacterium longum APC1472 | FPG- Mean difference of 4.788 (95% CI [7.92-1.62]) | 12 weeks | [33] |
Ecologic® Barrier (multi-strain probiotics) Bifidobacterium Lactis, Lactobacillus Acidophilus, Lactobacillus Salivarius, Lactobacillus Casei, Bifidobacterium Bifidum, | Decrease in HOMA IR- by 64% Insulin by 38% Glucose by 38% | 6 months | [34] |
| Lactobacillus casei 01 | Fasting blood sugar -28.32 [-50.23 to -6.41], 0.013 insulin concentration -3.12 [-5.90 to -0.35], 0.028 insulin resistance -32.31 [-55.09 to -9.54], 0.007 | 8 weeks | [35] |
| “Symbiter” (multi-strain) | HOMA-IR decreased from 6.85 ± 0.76 to 5.13 ± 0.49 (p = 0.047) HbA1C decreased by 0.24% (p = 0.068) | 8 weeks | [36] |
Table 2: Comparison of various probiotics in their efficacy in reducing glycaemic parameters.
The comprehensive review of the various RCTs and Meta-analysis updated to the latest article, clearly signifies the positive impact of Probiotics in the gradual reversal of insulin resistance, glycaemic control
and increased glucose uptake and the glycaemic efficacy of various probiotics have been summarised in table 2. The various mechanisms substantiating this result as mentioned in the above section strengthens the need to imply this importance in addressing the type 2 diabetic patients in clinical healthcare settings.
In summary, the multifaceted effects of probiotics on glucose homeostasis encompass the modulation of gut microbiota, the regulation of the gut-brain axis, and the reduction of chronic low-grade inflammation. While these mechanisms provide valuable insights, ongoing research is essential to fully elucidate the complex interplay and identify specific strains, doses, and durations of probiotic supplementation required for optimal glycaemic control in T2DM.
Future perspectives
Microbiome-Targeted Therapies:
As our understanding deepens, there is a growing interest in microbiome-targeted therapies for T2DM. Precision medicine approaches may involve identifying and utilizing specific probiotic strains that exhibit superior efficacy in modulating gut microbiota and influencing the gut-brain axis. Customized interventions based on an individual's microbiome profile could pave the way for personalized probiotic regimens tailored to address the unique microbial composition and metabolic needs of each patient.
Unexplored Pathways and Future Research Directions:
While the mechanisms discussed provide valuable insights, it is crucial to acknowledge the vastness of unexplored pathways that may contribute to the effects of probiotics on glucose homeostasis. Future research endeavours should focus on unveiling these hidden pathways, possibly involving intricate interactions between the immune system, metabolic organs, and the gut. Cutting-edge technologies, such as metagenomics and advanced imaging, hold promise in unravelling the complexities of the gut microbiome and its role in metabolic health.
Strain-Specific Effects and Optimal Dosages:
The identification of strain-specific effects remains a priority in shaping the future of probiotic research for T2DM. Different strains may exhibit varying abilities to modulate gut microbiota and influence metabolic pathways. Thus, delineating the specific strains responsible for the observed benefits is crucial for designing targeted interventions. Moreover, optimizing probiotic doses and duration of supplementation is essential, as these factors may significantly impact the efficacy of probiotics in improving glycemic control.
Clinical Translation and Therapeutic Potential:
As the scientific community continues to unravel the intricacies of probiotic mechanisms, the translation of research findings into clinical practice becomes paramount. Establishing robust clinical trials, exploring long-term effects, and addressing safety considerations will be critical steps in validating the therapeutic potential of probiotics in the management of T2DM. This translational approach will bridge the gap between experimental evidence and real-world applications, ultimately shaping evidence-based guidelines for healthcare practitioners.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
